Is bariatric surgery improving mitochondrial function in the renal cells of patients with obesity-induced kidney disease?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE
    • Publication Information:
      Publication: Oct. 2015- : Amsterdam ; Elsevier
      Original Publication: London ; San Diego : Academic Press, c1989-
    • Subject Terms:
      Obesity, Morbid*/surgery ; Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/surgery ; Bariatric Surgery*/methods ; Renal Insufficiency, Chronic*; Humans ; Obesity/complications ; Obesity/surgery ; Mitochondria
    • Abstract:
      The role of mitochondria in health and disease has dramatically changed in the last decade. Its complex integration into cell physiology is comprised of key metabolic functions of great importance in health maintenance. Treating obesity seems to improve overall mitochondria tissue malfunction; however, the extent of their impact on patients remains elusive due to the lack of follow-up studies. It has been observed that procedures such as bariatric surgery (BS) can modify how our body absorbs nutrients, influencing metabolic processes and mitochondrial function in several cells and tissues. In fact, tissue analysis performed in vivo and in patients support that BS mitigates mitochondrial dysfunction in obese subjects. BS has been observed to reduce the presence of comorbidities such as type 2 diabetes (T2D) and hypertension (HTN) in patients. It is still unclear how BS specifically affects mitochondrial dynamics in obesity-induced comorbidities such as kidney disease. This article provides insightful information regarding the amelioration of mitochondrial dynamics in renal cells and systems after BS. Understanding the multiple pathways that lead to mitochondrial dysregulation in obesity-related kidney disease and relating them to the positive molecular changes after BS may lead to the development of adjuvant therapies to control this and other conditions with similar pathophysiological backgrounds.
      Competing Interests: Conflict of interest The authors declare that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2022 Elsevier Ltd. All rights reserved.)
    • Contributed Indexing:
      Keywords: Bariatric surgery; Chronic kidney disease; Mitochondria; Mitochondrial function; Obesity-induced kidney disease; Renal cells
    • Publication Date:
      Date Created: 20221007 Date Completed: 20221108 Latest Revision: 20221108
    • Publication Date:
      20221213
    • Accession Number:
      10.1016/j.phrs.2022.106488
    • Accession Number:
      36206957